Crossmark

Indirect comparison of efficacy and safety between immune checkpoint inhibitors and antiangiogenic therapy in advanced non–small-cell lung cancer

Published Online: 2018-06-26

Authors

Chen, Jin-Hua

Yang, Jia-Lian

Chou, Che-Yi https://orcid.org/0000-0003-4029-9097
Wang, Jiun-Yi

Hung, Chin-Chuan
License Information

Text and Data Mining valid from 2018-06-26

Version of Record valid from 2018-06-26
More Information

Article History

Received: 20 October 2017

Accepted: 14 June 2018

First Online: 26 June 2018

Competing Interests

: The authors declare no competing interests.

Document is current